Hopson Ricky
Pres. BioProduct Delivery, CoS at CTLT
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Aug 2, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CTLTCatalent, Inc.Pres. BioProduct Delivery, CoS
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CTLTPlan not statedJan 23 2023
Sold 643 shares at $49.36 ($32k)
Hopson Ricky, Pres. Clinical Dev Supply Div
Sold 3.8% of holdings ($844k position)16,452 shares left0.4x usual sizeFiling
- 2 Form 144 notice CTLTNoticeAug 1 +190 days
Filed to sell 195 shares ($9k)
Hopson Ricky, Officer
No 10b5-1 plan0.1x usual sizeFiling
- 3 Form 4 sale CTLTNo planAug 1 same day
Sold 195 shares at $47.86 ($9k)
Hopson Ricky, Pres. Clinical Dev Supply Div
No 10b5-1 planSold 1.2% of holdings ($787k position)16,257 shares left0.1x usual sizeFollows a Form 144Filing
- 4 Form 144 notice CTLTNoticeAug 24 +23 days
Filed to sell 276 shares ($12k)
Hopson Ricky, Officer
No 10b5-1 plan0.2x usual sizeFiling
- 5 Form 4 sale CTLTNo planAug 24 same day
Sold 276 shares at $44.56 ($12k)
Hopson Ricky, Pres. Clinical Dev Supply Div
No 10b5-1 planSold 1.2% of holdings ($994k position)22,040 shares left0.2x usual sizeFollows a Form 144Filing
- 6 Form 4 sale CTLTNo planJun 4 +285 days
Sold 1,401 shares at $54.26 ($76k)
Hopson Ricky, Pres. BioProduct Delivery, CoS
No 10b5-1 planSold 6.4% of holdings ($1.2M position)20,617 shares left1.8x usual sizeFiling
- 7 Form 4 sale CTLTNo planJul 29 +55 days
Sold 206 shares at $58.67 ($12k)
Hopson Ricky, Pres. BioProduct Delivery, CoS
No 10b5-1 planSold 0.7% of holdings ($1.8M position)30,636 shares left0.2x usual sizeFiling
- 8 Form 4 sale CTLTNo planAug 2 +4 days
Sold 662 shares at $59.56 ($39k)
Hopson Ricky, Pres. BioProduct Delivery, CoS
No 10b5-1 planSold 2.2% of holdings ($1.8M position)29,974 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (14)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | CTLT | Pres. BioProduct Delivery, CoS | Form 4 sale | 662 | $39k | 2.2% | No plan | SEC |
| Jul 29, 2024 | CTLT | Pres. BioProduct Delivery, CoS | Form 4 sale | 206 | $12k | 0.7% | No plan | SEC |
| Jun 4, 2024 | CTLT | Pres. BioProduct Delivery, CoS | Form 4 sale | 1,401 | $76k | 6.4% | No plan | SEC |
| Aug 24, 2023 | CTLT | Pres. Clinical Dev Supply Div | Form 4 sale | 276 | $12k | 1.2% | No plan | SEC |
| Aug 24, 2023 | CTLT | Officer | Form 144 notice | 276 | $12k | Notice | SEC | |
| Aug 1, 2023 | CTLT | Pres. Clinical Dev Supply Div | Form 4 sale | 195 | $9k | 1.2% | No plan | SEC |
| Aug 1, 2023 | CTLT | Officer | Form 144 notice | 195 | $9k | Notice | SEC | |
| Jan 23, 2023 | CTLT | Pres. Clinical Dev Supply Div | Form 4 sale | 643 | $32k | 3.8% | Plan not stated | SEC |
| Aug 31, 2022 | CTLT | Pres. Clinical Dev Supply Div | Form 4 sale | 2,216 | $199k | 11.5% | Plan not stated | SEC |
| Aug 25, 2022 | CTLT | Pres. Clinical Dev Supply Div | Form 4 sale | 1,517 | $156k | 7.3% | Plan not stated | SEC |
| Jul 27, 2022 | CTLT | Pres, Clinical Dev & Supply | Form 4 sale | 903 | $97k | 5.0% | Plan not stated | SEC |
| Jan 31, 2022 | CTLT | VP, Chief Accounting Officer | Form 4 sale | 2,325 | $240k | 12.0% | Plan not stated | SEC |
| Aug 27, 2021 | CTLT | VP, Chief Accounting Officer | Form 4 sale | 1,471 | $193k | 7.0% | Plan not stated | SEC |
| Jul 26, 2021 | CTLT | VP, Chief Accounting Officer | Form 4 sale | 360 | $41k | 2.2% | Plan not stated | SEC |